[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Human Coagulation Factor VII Market Report 2017

October 2017 | 97 pages | ID: U1D56BBDFE8PEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Human Coagulation Factor VII market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Human Coagulation Factor VII in these regions, from 2012 to 2022 (forecast).
United States Human Coagulation Factor VII market competition by top manufacturers/players, with Human Coagulation Factor VII sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Baxter
  • Bayer
  • CSL'
  • Pfizer
  • Grifols
  • Biogen
  • Octapharma
  • NovoNordisk
  • Greencross
  • Kedrion
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Recombinant Factor VIII
  • Plasma-derived Factor VIII
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Human Coagulation Factor VII for each application, including
  • Hemophilia A
  • Spontanous / Trauma
  • Surgical
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Human Coagulation Factor VII Market Report 2017

1 HUMAN COAGULATION FACTOR VII OVERVIEW

1.1 Product Overview and Scope of Human Coagulation Factor VII
1.2 Classification of Human Coagulation Factor VII by Product Category
  1.2.1 United States Human Coagulation Factor VII Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Human Coagulation Factor VII Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Recombinant Factor VIII
  1.2.4 Plasma-derived Factor VIII
1.3 United States Human Coagulation Factor VII Market by Application/End Users
  1.3.1 United States Human Coagulation Factor VII Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hemophilia A
  1.3.3 Spontanous / Trauma
  1.3.4 Surgical
  1.3.5 Other
1.4 United States Human Coagulation Factor VII Market by Region
  1.4.1 United States Human Coagulation Factor VII Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Human Coagulation Factor VII Status and Prospect (2012-2022)
  1.4.3 Southwest Human Coagulation Factor VII Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Human Coagulation Factor VII Status and Prospect (2012-2022)
  1.4.5 New England Human Coagulation Factor VII Status and Prospect (2012-2022)
  1.4.6 The South Human Coagulation Factor VII Status and Prospect (2012-2022)
  1.4.7 The Midwest Human Coagulation Factor VII Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Human Coagulation Factor VII (2012-2022)
  1.5.1 United States Human Coagulation Factor VII Sales and Growth Rate (2012-2022)
  1.5.2 United States Human Coagulation Factor VII Revenue and Growth Rate (2012-2022)

2 UNITED STATES HUMAN COAGULATION FACTOR VII MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Human Coagulation Factor VII Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Human Coagulation Factor VII Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Human Coagulation Factor VII Average Price by Players/Suppliers (2012-2017)
2.4 United States Human Coagulation Factor VII Market Competitive Situation and Trends
  2.4.1 United States Human Coagulation Factor VII Market Concentration Rate
  2.4.2 United States Human Coagulation Factor VII Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Human Coagulation Factor VII Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HUMAN COAGULATION FACTOR VII SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Human Coagulation Factor VII Sales and Market Share by Region (2012-2017)
3.2 United States Human Coagulation Factor VII Revenue and Market Share by Region (2012-2017)
3.3 United States Human Coagulation Factor VII Price by Region (2012-2017)

4 UNITED STATES HUMAN COAGULATION FACTOR VII SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Human Coagulation Factor VII Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Human Coagulation Factor VII Revenue and Market Share by Type (2012-2017)
4.3 United States Human Coagulation Factor VII Price by Type (2012-2017)
4.4 United States Human Coagulation Factor VII Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HUMAN COAGULATION FACTOR VII SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Human Coagulation Factor VII Sales and Market Share by Application (2012-2017)
5.2 United States Human Coagulation Factor VII Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HUMAN COAGULATION FACTOR VII PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Baxter
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Coagulation Factor VII Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Baxter Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bayer
  6.2.2 Human Coagulation Factor VII Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 CSL?
  6.3.2 Human Coagulation Factor VII Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CSL? Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Human Coagulation Factor VII Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Grifols
  6.5.2 Human Coagulation Factor VII Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Grifols Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Biogen
  6.6.2 Human Coagulation Factor VII Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Biogen Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Octapharma
  6.7.2 Human Coagulation Factor VII Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Octapharma Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 NovoNordisk
  6.8.2 Human Coagulation Factor VII Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 NovoNordisk Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Greencross
  6.9.2 Human Coagulation Factor VII Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Greencross Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Kedrion
  6.10.2 Human Coagulation Factor VII Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Kedrion Human Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 HUMAN COAGULATION FACTOR VII MANUFACTURING COST ANALYSIS

7.1 Human Coagulation Factor VII Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Coagulation Factor VII

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Coagulation Factor VII Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Coagulation Factor VII Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HUMAN COAGULATION FACTOR VII MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Human Coagulation Factor VII Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Human Coagulation Factor VII Sales Volume Forecast by Type (2017-2022)
11.3 United States Human Coagulation Factor VII Sales Volume Forecast by Application (2017-2022)
11.4 United States Human Coagulation Factor VII Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Human Coagulation Factor VII
Figure United States Human Coagulation Factor VII Market Size (K Units) by Type (2012-2022)
Figure United States Human Coagulation Factor VII Sales Volume Market Share by Type (Product Category) in 2016
Figure Recombinant Factor VIII Product Picture
Figure Plasma-derived Factor VIII Product Picture
Figure United States Human Coagulation Factor VII Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Human Coagulation Factor VII by Application in 2016
Figure Hemophilia A Examples
Table Key Downstream Customer in Hemophilia A
Figure Spontanous / Trauma Examples
Table Key Downstream Customer in Spontanous / Trauma
Figure Surgical Examples
Table Key Downstream Customer in Surgical
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Human Coagulation Factor VII Market Size (Million USD) by Region (2012-2022)
Figure The West Human Coagulation Factor VII Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Human Coagulation Factor VII Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Human Coagulation Factor VII Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Human Coagulation Factor VII Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Human Coagulation Factor VII Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Human Coagulation Factor VII Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Coagulation Factor VII Sales (K Units) and Growth Rate (2012-2022)
Figure United States Human Coagulation Factor VII Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Coagulation Factor VII Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Human Coagulation Factor VII Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Human Coagulation Factor VII Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Coagulation Factor VII Sales Share by Players/Suppliers
Figure 2017 United States Human Coagulation Factor VII Sales Share by Players/Suppliers
Figure United States Human Coagulation Factor VII Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Human Coagulation Factor VII Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Human Coagulation Factor VII Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Coagulation Factor VII Revenue Share by Players/Suppliers
Figure 2017 United States Human Coagulation Factor VII Revenue Share by Players/Suppliers
Table United States Market Human Coagulation Factor VII Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Human Coagulation Factor VII Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Human Coagulation Factor VII Market Share of Top 3 Players/Suppliers
Figure United States Human Coagulation Factor VII Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Human Coagulation Factor VII Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Human Coagulation Factor VII Product Category
Table United States Human Coagulation Factor VII Sales (K Units) by Region (2012-2017)
Table United States Human Coagulation Factor VII Sales Share by Region (2012-2017)
Figure United States Human Coagulation Factor VII Sales Share by Region (2012-2017)
Figure United States Human Coagulation Factor VII Sales Market Share by Region in 2016
Table United States Human Coagulation Factor VII Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Human Coagulation Factor VII Revenue Share by Region (2012-2017)
Figure United States Human Coagulation Factor VII Revenue Market Share by Region (2012-2017)
Figure United States Human Coagulation Factor VII Revenue Market Share by Region in 2016
Table United States Human Coagulation Factor VII Price (USD/Unit) by Region (2012-2017)
Table United States Human Coagulation Factor VII Sales (K Units) by Type (2012-2017)
Table United States Human Coagulation Factor VII Sales Share by Type (2012-2017)
Figure United States Human Coagulation Factor VII Sales Share by Type (2012-2017)
Figure United States Human Coagulation Factor VII Sales Market Share by Type in 2016
Table United States Human Coagulation Factor VII Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Human Coagulation Factor VII Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human Coagulation Factor VII by Type (2012-2017)
Figure Revenue Market Share of Human Coagulation Factor VII by Type in 2016
Table United States Human Coagulation Factor VII Price (USD/Unit) by Types (2012-2017)
Figure United States Human Coagulation Factor VII Sales Growth Rate by Type (2012-2017)
Table United States Human Coagulation Factor VII Sales (K Units) by Application (2012-2017)
Table United States Human Coagulation Factor VII Sales Market Share by Application (2012-2017)
Figure United States Human Coagulation Factor VII Sales Market Share by Application (2012-2017)
Figure United States Human Coagulation Factor VII Sales Market Share by Application in 2016
Table United States Human Coagulation Factor VII Sales Growth Rate by Application (2012-2017)
Figure United States Human Coagulation Factor VII Sales Growth Rate by Application (2012-2017)
Table Baxter Basic Information List
Table Baxter Human Coagulation Factor VII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Baxter Human Coagulation Factor VII Sales Growth Rate (2012-2017)
Figure Baxter Human Coagulation Factor VII Sales Market Share in United States (2012-2017)
Figure Baxter Human Coagulation Factor VII Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Human Coagulation Factor VII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Human Coagulation Factor VII Sales Growth Rate (2012-2017)
Figure Bayer Human Coagulation Factor VII Sales Market Share in United States (2012-2017)
Figure Bayer Human Coagulation Factor VII Revenue Market Share in United States (2012-2017)
Table CSL? Basic Information List
Table CSL? Human Coagulation Factor VII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CSL? Human Coagulation Factor VII Sales Growth Rate (2012-2017)
Figure CSL? Human Coagulation Factor VII Sales Market Share in United States (2012-2017)
Figure CSL? Human Coagulation Factor VII Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Human Coagulation Factor VII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Human Coagulation Factor VII Sales Growth Rate (2012-2017)
Figure Pfizer Human Coagulation Factor VII Sales Market Share in United States (2012-2017)
Figure Pfizer Human Coagulation Factor VII Revenue Market Share in United States (2012-2017)
Table Grifols Basic Information List
Table Grifols Human Coagulation Factor VII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Grifols Human Coagulation Factor VII Sales Growth Rate (2012-2017)
Figure Grifols Human Coagulation Factor VII Sales Market Share in United States (2012-2017)
Figure Grifols Human Coagulation Factor VII Revenue Market Share in United States (2012-2017)
Table Biogen Basic Information List
Table Biogen Human Coagulation Factor VII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biogen Human Coagulation Factor VII Sales Growth Rate (2012-2017)
Figure Biogen Human Coagulation Factor VII Sales Market Share in United States (2012-2017)
Figure Biogen Human Coagulation Factor VII Revenue Market Share in United States (2012-2017)
Table Octapharma Basic Information List
Table Octapharma Human Coagulation Factor VII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Octapharma Human Coagulation Factor VII Sales Growth Rate (2012-2017)
Figure Octapharma Human Coagulation Factor VII Sales Market Share in United States (2012-2017)
Figure Octapharma Human Coagulation Factor VII Revenue Market Share in United States (2012-2017)
Table NovoNordisk Basic Information List
Table NovoNordisk Human Coagulation Factor VII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure NovoNordisk Human Coagulation Factor VII Sales Growth Rate (2012-2017)
Figure NovoNordisk Human Coagulation Factor VII Sales Market Share in United States (2012-2017)
Figure NovoNordisk Human Coagulation Factor VII Revenue Market Share in United States (2012-2017)
Table Greencross Basic Information List
Table Greencross Human Coagulation Factor VII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Greencross Human Coagulation Factor VII Sales Growth Rate (2012-2017)
Figure Greencross Human Coagulation Factor VII Sales Market Share in United States (2012-2017)
Figure Greencross Human Coagulation Factor VII Revenue Market Share in United States (2012-2017)
Table Kedrion Basic Information List
Table Kedrion Human Coagulation Factor VII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Kedrion Human Coagulation Factor VII Sales Growth Rate (2012-2017)
Figure Kedrion Human Coagulation Factor VII Sales Market Share in United States (2012-2017)
Figure Kedrion Human Coagulation Factor VII Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Coagulation Factor VII
Figure Manufacturing Process Analysis of Human Coagulation Factor VII
Figure Human Coagulation Factor VII Industrial Chain Analysis
Table Raw Materials Sources of Human Coagulation Factor VII Major Players/Suppliers in 2016
Table Major Buyers of Human Coagulation Factor VII
Table Distributors/Traders List
Figure United States Human Coagulation Factor VII Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Human Coagulation Factor VII Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Human Coagulation Factor VII Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Human Coagulation Factor VII Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Human Coagulation Factor VII Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Human Coagulation Factor VII Sales Volume (K Units) Forecast by Type in 2022
Table United States Human Coagulation Factor VII Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Human Coagulation Factor VII Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Human Coagulation Factor VII Sales Volume (K Units) Forecast by Application in 2022
Table United States Human Coagulation Factor VII Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Human Coagulation Factor VII Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Coagulation Factor VII Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Coagulation Factor VII Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications